Cargando…
Identification of key genes, biological functions, and pathways of empagliflozin by network pharmacology and its significance in the treatment of type 2 diabetes mellitus
BACKGROUND: To explore the key genes, biological functions, and pathways of empagliflozin in the treatment of type 2 diabetes mellitus (T2DM) through network pharmacology. METHODS: The TCMSP (a traditional Chinese medicine system pharmacology database and analysis platform) was used to screen empagl...
Autores principales: | Zhong, Heng, Duan, Bin-Hong, Du, Fu-Man, Wang, Wei-Min, Qiao, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929817/ https://www.ncbi.nlm.nih.gov/pubmed/36819540 http://dx.doi.org/10.21037/atm-22-6406 |
Ejemplares similares
-
Identification of the active compounds and significant pathways of yinchenhao decoction based on network pharmacology
por: Huang, Jihan, et al.
Publicado: (2017) -
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
por: Munir, Kashif M, et al.
Publicado: (2016) -
Options for empagliflozin in combination therapy in type 2 diabetes mellitus
por: Hershon, Kenneth S
Publicado: (2016) -
Pharmacological analysis of Empagliflozin: Acting through the CaMKII pathway in type 2 diabetes and acute cardiovascular events
por: Shao, Guangyao
Publicado: (2022) -
Identification of the significant pathways of Banxia Houpu decoction in the treatment of depression based on network pharmacology
por: Chen, Zi-ying, et al.
Publicado: (2020)